Publicacións nas que colabora con ARANZAZU SÁNCHEZ MUÑOZ (41)

2024

  1. Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression

    Cell Death and Disease, Vol. 15, Núm. 9

  2. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495

  3. Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2339-2355

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2020

  1. A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival

    Cells, Vol. 9, Núm. 3

  2. Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR

    Frontiers in Immunology, Vol. 11

  3. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer

    Journal of Hepatology, Vol. 72, Núm. 1, pp. 125-134

  4. Editorial Special Issue TGF-beta/BMP Signaling Pathway

    Cells

2019

  1. c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch

    Stem Cells, Vol. 37, Núm. 8, pp. 1108-1118

2018

  1. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury

    Liver International, Vol. 38, Núm. 9, pp. 1664-1675

2016

  1. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 604-619

  2. TGF-β signalling and liver disease

    FEBS Journal, pp. 2219-2232

  3. The rationale for targeting TGF-β in chronic liver diseases

    European Journal of Clinical Investigation, Vol. 46, Núm. 4, pp. 349-361

2015

  1. BMP9-induced survival effect in liver tumor cells requires p38MAPK activation

    International Journal of Molecular Sciences, Vol. 16, Núm. 9, pp. 20431-20448

  2. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 10, pp. 2453-2463

2014

  1. Polμ deficiency increases resistance to oxidative damage and delays liver aging

    PLoS ONE, Vol. 9, Núm. 4

  2. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression

    Free Radical Biology and Medicine, Vol. 69, pp. 338-347

2013

  1. BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells

    PLoS ONE, Vol. 8, Núm. 7

  2. Mouse Hepatic Oval Cells Require Met-Dependent PI3K to Impair TGF-β-Induced Oxidative Stress and Apoptosis

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. BMPS and liver: More questions than answers

    Current Pharmaceutical Design, Vol. 18, Núm. 27, pp. 4114-4125